George Kurian - Cigna Corp Independent Director
| CI Stock | USD 281.58 1.52 0.54% |
Director
George Kurian is Independent Director of Cigna Corp since 2021.
| Age | 54 |
| Tenure | 3 years |
| Address | 900 Cottage Grove Road, Bloomfield, CT, United States, 06002 |
| Phone | 860 226 6000 |
| Web | https://www.cigna.com |
George Kurian Latest Insider Activity
Tracking and analyzing the buying and selling activities of George Kurian against Cigna Corp stock is an integral part of due diligence when investing in Cigna Corp. George Kurian insider activity provides valuable insight into whether Cigna Corp is net buyers or sellers over its current business cycle. Note, Cigna Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cigna Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
George Kurian over three weeks ago Acquisition by George Kurian of tradable shares of Cigna Corp subject to Rule 16b-3 | ||
George Kurian over three months ago Disposition of 6259 shares by George Kurian of NetApp at 130.49 subject to Rule 16b-3 | ||
George Kurian over six months ago Disposition of 13875 shares by George Kurian of NetApp subject to Rule 16b-3 |
Cigna Corp Management Efficiency
The company has Return on Asset (ROA) of 0.028 % which means that for every $100 of assets, it generated a profit of $0.028. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.0761 %, which means that it produced $0.0761 on every 100 dollars invested by current stockholders. Cigna Corp's management efficiency ratios could be used to measure how well Cigna Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ramona Sequeira | Edwards Lifesciences Corp | 55 | |
| Angela Fuente | Edwards Lifesciences Corp | N/A | |
| Martha Marsh | Edwards Lifesciences Corp | 72 | |
| Paul Sekhri | Veeva Systems Class | 62 | |
| Mark Carges | Veeva Systems Class | 57 | |
| Paul LaViolette | Edwards Lifesciences Corp | 63 | |
| Gunnar Hansen | Veeva Systems Class | N/A | |
| Paul Chamberlain | Veeva Systems Class | 56 | |
| Ronald Codd | Veeva Systems Class | 64 | |
| Leslie Heisz | Edwards Lifesciences Corp | 60 | |
| Timothy Barabe | Veeva Systems Class | 67 | |
| William Link | Edwards Lifesciences Corp | 73 | |
| Timothy Cabral | Veeva Systems Class | 57 | |
| Steven Loranger | Edwards Lifesciences Corp | 69 | |
| Nicholas Valeriani | Edwards Lifesciences Corp | 64 | |
| Kieran Gallahue | Edwards Lifesciences Corp | 57 | |
Management Performance
| Return On Equity | 0.0761 | ||||
| Return On Asset | 0.028 |
Cigna Corp Leadership Team
Elected by the shareholders, the Cigna Corp's board of directors comprises two types of representatives: Cigna Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cigna. The board's role is to monitor Cigna Corp's management team and ensure that shareholders' interests are well served. Cigna Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cigna Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arjan Toor, Chief Operations | ||
| Nicole Jones, Executive Vice President, General Counsel | ||
| Matthew Manders, President of U.S. Commercial Markets and Global Health Care Operations | ||
| Donna Zarcone, Independent Director | ||
| Noelle Eder, Executive Vice President, Global Chief Information Officer | ||
| Eric Palmer, Chief Financial Officer, Executive Vice President | ||
| Dean Mirabella, President Markets | ||
| John Webb, President - Health Care | ||
| Cynthia Ryan, Chief Human Resource Officer | ||
| Alexis Jones, Investor Principal | ||
| Mark Boxer, Executive Vice President, Chief Information Officer | ||
| Neesha Hathi, Independent Director | ||
| Nicole JD, Chief VP | ||
| Adam PharmD, President Services | ||
| Jason Sadler, President of International Markets | ||
| Eric Foss, Independent Director | ||
| Timothy Wentworth, Chief Executive Officer - Evernorth | ||
| Isaiah Harris, Independent Chairman of the Board | ||
| John Murabito, Executive Vice President - Human Resources, Chief Administrative Officer | ||
| Christopher MBA, President Businesses | ||
| Roman Martinez, Independent Director | ||
| William DeLaney, Independent Director | ||
| Kristen Lauria, Executive Vice President, Chief Marketing Officer | ||
| Everett Neville, Executive Vice President, Strategy, Corporate Development and Solutions | ||
| Ralph Giacobbe, Senior Relations | ||
| Phil Austin, Head Markets | ||
| Paul Sanford, Executive Vice President - Operations | ||
| John Partridge, Independent Director | ||
| Jamie Kates, Chief Officer | ||
| Mark McClellan, Independent Director | ||
| Kathleen Mazzarella, Independent Director | ||
| Mary CPA, Senior Officer | ||
| MICHAEL TRIPLETT, President - U.S. Commercial | ||
| Steven Miller, Executive Vice President Chief Clinical Officer | ||
| Elder Granger, Independent Director | ||
| Kimberly Ross, Independent Director | ||
| Mary Picerno, Chief Officer | ||
| Brian CFA, CFO VP | ||
| Eric Wiseman, Lead Independent Director | ||
| Brian Evanko, Chief Financial Officer, Executive Vice President | ||
| Matt Perlberg, Pharmacy President | ||
| Kari Stevens, Chief VP | ||
| David Cordani, CEO and President Director and Member of Executive Committee | ||
| Terese CPA, Senior Officer | ||
| William Roper, Independent Director | ||
| George Kurian, Independent Director | ||
| Charles Berg, President - U.S. Government Business |
Cigna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cigna Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0761 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 105.25 B | ||||
| Shares Outstanding | 278.15 M | ||||
| Shares Owned By Insiders | 1.58 % | ||||
| Shares Owned By Institutions | 89.52 % | ||||
| Number Of Shares Shorted | 3.19 M | ||||
| Price To Earning | 13.93 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.45) | Dividend Share 5.43 | Earnings Share 10.56 | Revenue Per Share 808.024 | Quarterly Revenue Growth 0.28 |
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.